$12.51
-0.3-2.34%
Last update: 10:59 AM
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | YMAB | Y-mAbs Therapeutics | FY | 2024 | — | — | — | $95.00M | $100.00M | $97.16M | Get Alert |
02/29/2024 | YMAB | Y-mAbs Therapeutics | FY | 2024 | — | — | — | $95.00M | $100.00M | $96.27M | Get Alert |
01/09/2024 | YMAB | Y-mAbs Therapeutics | FY | 2023 | — | — | — | $80.00M | $85.00M | $82.39M | Get Alert |
11/13/2023 | YMAB | Y-mAbs Therapeutics | FY | 2023 | — | — | — | $80.00M | $85.00M | $83.76M | Get Alert |
08/10/2023 | YMAB | Y-mAbs Therapeutics | FY | 2023 | — | — | — | $80.00M | $85.00M | $82.79M | Get Alert |
11/07/2022 | YMAB | Y-mAbs Therapeutics | FY | 2022 | — | — | — | $45.00M | $50.00M | $51.75M | Get Alert |
08/08/2022 | YMAB | Y-mAbs Therapeutics | FY | 2022 | — | — | — | $45.00M | $50.00M | $60.18M | Get Alert |
04/27/2022 | YMAB | Y-mAbs Therapeutics | Q1 | 2022 | — | — | — | $10.50M | $10.50M | $10.99M | Get Alert |
04/27/2022 | YMAB | Y-mAbs Therapeutics | FY | 2022 | — | — | — | $45.00M | $50.00M | $67.81M | Get Alert |
There have been no specific sales or earnings guidance reported for Y-mAbs Therapeutics in recent months.
Browse guidance and forecast on all stocks.